Source:http://linkedlifedata.com/resource/pubmed/id/14630701
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2004-1-13
|
pubmed:abstractText |
E-selectin mediated cell-cell adhesion plays an important role in inflammatory processes and extravasation of tumor cells. Tumor necrosis factor-alpha (TNF-alpha) induces E-selectin gene and protein expression in primary human endothelial cells (HUVEC) and in an endothelial cell line (EA.hy-926). As shown by ELISA and FACS analyses, HMG-CoA reductase inhibitors (e.g., lovastatin) impair the TNF-alpha stimulated increase in E-selectin protein expression. Similar results were obtained for E-selectin mRNA expression and promoter activity, indicating that the effect of lovastatin is based on inhibition of gene expression. The effective inhibitory concentration of lovastatin was in a physiologically relevant range (IC50<0.1 microM). Lovastatin-mediated block of TNF-alpha induced E-selectin expression is due to inhibition of protein geranylgeranylation rather than farnesylation. Down-regulation of Rho signaling by coexpression of dominant-negative Rho mutants (i.e RhoA, RhoB and Rac) impaired TNF-alpha driven E-selectin gene expression, indicating Rho signaling to be essential for transcriptional activation of the E-selectin gene. Inhibition of E-selectin expression by lovastatin gives rise to a significant reduction in TNF-alpha stimulated adhesion of colon carcinoma cells to HUVEC. Furthermore, low concentration of lovastatin (i.e., < or =1 microM) attenuated TNF-alpha induced tumor cell invasion in vitro. The data support the view that statins might be clinically useful in protection against E-selectin mediated metastasis.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents,
http://linkedlifedata.com/resource/pubmed/chemical/E-Selectin,
http://linkedlifedata.com/resource/pubmed/chemical/Lovastatin,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Necrosis Factor-alpha,
http://linkedlifedata.com/resource/pubmed/chemical/rho GTP-Binding Proteins
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
1530-6860
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
18
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
140-2
|
pubmed:dateRevised |
2005-11-17
|
pubmed:meshHeading |
pubmed-meshheading:14630701-Antineoplastic Agents,
pubmed-meshheading:14630701-Cell Adhesion,
pubmed-meshheading:14630701-Cell Line, Tumor,
pubmed-meshheading:14630701-Cell Movement,
pubmed-meshheading:14630701-Cells, Cultured,
pubmed-meshheading:14630701-E-Selectin,
pubmed-meshheading:14630701-Endothelium, Vascular,
pubmed-meshheading:14630701-Humans,
pubmed-meshheading:14630701-Lovastatin,
pubmed-meshheading:14630701-Neoplasms,
pubmed-meshheading:14630701-Signal Transduction,
pubmed-meshheading:14630701-Transcription, Genetic,
pubmed-meshheading:14630701-Tumor Necrosis Factor-alpha,
pubmed-meshheading:14630701-rho GTP-Binding Proteins
|
pubmed:year |
2004
|
pubmed:articleTitle |
Lovastatin inhibits Rho-regulated expression of E-selectin by TNFalpha and attenuates tumor cell adhesion.
|
pubmed:affiliation |
University of Mainz, Institute of Toxicology, Division of Applied Toxicology, Mainz, Germany.
|
pubmed:publicationType |
Journal Article
|